Henry Schein stock rises after Q2 earnings beat
Published on 09/04/2026 at 16:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Henry Schein (US42548G1040) stock is trading on a stronger 2026 outlook after second-quarter 2026 results showed net sales of USD 3.458 billion, up 6.7 percent year over year, and non-GAAP diluted EPS of USD 1.27, up 15.5 percent, according to Henry Schein's 8-K summary. The same filing says the company raised 2026 guidance to non-GAAP diluted EPS of USD 5.29 to USD 5.39 and total sales growth of 4.5 percent to 5.5 percent.
Q2 sales and margins
Operating income in the quarter reached USD 171 million, up 13.2 percent, while gross profit rose to USD 1.10 billion and gross margin widened to 31.8 percent. Adjusted EBITDA increased to USD 288 million from USD 256 million, and Henry Schein repurchased 2.6 million shares for USD 200 million.
For the first half of 2026, net sales were USD 6.826 billion, up 6.5 percent. That comparison matters because it shows the second quarter was not an isolated move but part of a broader half-year trend.
Guidance moved higher
The updated 2026 outlook now calls for mid to high-single-digit Adjusted EBITDA growth, after the company had previously guided to mid-single-digit growth. Zacks said on September 3, 2026 that the stock had added 0.9 percent since the last earnings report and that second-quarter adjusted EPS beat the consensus estimate by 4.1 percent.
Henry Schein revenue and guidance details
The latest filing adds the quarterly figures, the first-half total and the raised 2026 outlook in one place.
Dental distribution remains central
Henry Schein's core distribution business still drives most of the story, with Global Distribution and Value-Added Services sales up 6.6 percent to USD 2.91 billion and Global Specialty Products up 8.7 percent to USD 419 million. Global Technology rose 8.2 percent to USD 181 million, making technology the fastest-growing major reporting line in internal terms.
Stock level and market data
On September 4, 2026, Henry Schein stock traded at USD 73.50 on Nasdaq, with a market capitalization of USD 8.94 billion, after Reuters-linked market data showed the shares up 4.3 percent since the earnings report and trading at USD 90.27 in one U.S. market snapshot on September 3, 2026. The gap between the recent quote and the higher post-earnings level reflects how quickly the market has repriced the stronger second-quarter numbers.
Henry Schein stock facts
- Company: Henry Schein, Inc.
- ISIN: US42548G1040
- Ticker: HSIC
- Trading venue: Nasdaq
- Price (as of September 4, 2026): USD 73.50
- Market capitalization: USD 8.94 billion (as of September 4, 2026)
- Sector / Industry: Health Care / Healthcare Distributors
- Index membership: S&P 500
Dental products and software
The group sells healthcare products and services mainly to dental practices, medical offices and other healthcare facilities, and its mix now includes distribution, specialty products and technology. That mix matters because the latest quarter showed growth in each of the major reporting buckets, not just in one line.
September 4 trading view
Henry Schein stock closed the latest U.S. market snapshot at USD 73.50, and the higher guidance keeps the debate centered on execution into the next report.
